Category Archives: HIV/AIDS

Virtual CROI 2021: In opening talk Dr. Fauci looks at the “two-way street” of lessons from HIV and COVID-19

By on .

Transmitted by people without symptoms, hitting populations regarded too widely as “disposable,” its spread facilitated by claims the deadly public health threat is a hoax, and presenting lessons in research that include the critical roles of community engagement and of collaborative endeavors reaching across disciplines and national boundaries, HIV offered valuable lessons to scientists and […]

Lancet series highlights a vicious circle of inequities hobbling efforts to end disease spread

By on .

Steeped in inequities that include formidable barriers to basic health services for multitudes of its most vulnerable, marginalized and neglected people, the country leading global HIV responses, continues to fall far short of attainable goals to control its epidemic at home, a Lancet series of articles by leading HIV researchers released today shows. While the […]

COVID vaccines in HIV-Positive recipients: Need for more data from the Novavax South Africa study and with other vaccine platforms

By on .

By Daniel R. Lucey MD, MPH, FIDSA The Jan. 28 Novavax press release that included preliminary results from its COVID-19 vaccine Phase 2b trial in South Africa appears to contain a significant difference in efficacy between volunteers who were HIV-positive and HIV-negative. If verified, then the implications warrant sustained attention for this protein-based adjuvanted COVID-19 […]

First long-acting injectable treatment for HIV represents an exciting step forward, should be optimized with equity, investment

By on .

First long-acting injectable treatment for HIV represents an exciting step forward, should be optimized with equity, investment Dr. Rajesh Gandhi is the Co-Director of the Harvard Center for AIDS Research and the site leader of the MGH Clinical Research Site in the Harvard/Miriam AIDS Clinical Trials Unit and a scientific member of the Department of […]

How do I know which adolescent girls are at greatest risk for HIV?

By on .

Innovative approaches can help find vulnerable young women in need of HIV prevention services The following is a guest post by Michelle Li, MS, and Quinn Lewis, MIA, of Data.FI project In sub-Saharan Africa, adolescent girls and young women are disproportionately impacted by HIV and are more likely to become infected, compared to their male […]

It’s a puzzle, it’s an algorithm, it’s deduplication

By on .

The following is a guest post by Richard Ngethe, MBA,  and Jonathan Friedman, MS According to a study by UNAIDS of Brazil, of an estimated 140 million records in the national user database—including all health records—only 100 million unique patients were represented. The number of patients, therefore, was overstated by 40%.[1] This is the kind […]

Four recommendations can move Indonesia toward achieving HIV epidemic control

By on .

The following is a guest post by Cathy Cantelmo, Rebecca Ross, Shree Prabhakaran and Arin Dutta Indonesia has not yet achieved UNAIDS 90-90-90 HIV treatment targets or epidemic control. Of the people living with HIV as of June 2020, only 63 percent knew their status, just a quarter were on antiretroviral therapy, and a mere […]

A plan maintains continuity of HIV care in a Nigerian state during COVID-19 lockdown

By on .

The following is a guest post by Tyra Fom of Data.FI The COVID-19 pandemic poses a double threat for people living with HIV, who must find ways during lockdown to access their antiretroviral therapy from overwhelmed health facilities. In addition, people who have the virus but are not yet diagnosed face challenges getting tested and […]

To End the HIV Epidemic among Latinx populations, look at the big picture and zoom in

By on .

By Dr. Vincent Guilamo-Ramos and Dr. Barbara Taylor In February 2019, the federal government updated national HIV goals to end the epidemic in the U.S. by 2030. Those goals appeared to be coming into reach because of significant overall progress in the fight against HIV, with deaths attributed to HIV across the U.S. decreasing by approximately 4% […]

National Latinx AIDS Awareness Day: An overlooked crisis leads to missed opportunities

By on .

Dr. Vincent Guilamo-Ramos is the vice-chair of the board of directors of the Latino Commission on AIDS, and director and founder of the Center for Latino Adolescent and Family Health and the co-chair of the Ending the HIV Epidemic working group for the HIV Medicine Association, which produces this blog. Today, on National Latinx AIDS […]